These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6200969)

  • 1. Erythema multiforme following the infusion of hydroxyethyl starch.
    Klein RE; Mogollon G
    Transfusion; 1984; 24(2):166-7. PubMed ID: 6200969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor reaction to hydroxyethyl starch during granulocytapheresis.
    Dutcher JP; Aisner J; Hogge DE; Schiffer CA
    Transfusion; 1984; 24(1):66-7. PubMed ID: 6198788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor toxicity in granulocyte collections: association of lichen planus with the use of hydroxyethyl starch leukapheresis.
    Bode U; Deisseroth AB
    Transfusion; 1981; 21(1):83-5. PubMed ID: 6162256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does hydroxyethyl starch cause lichen planus? Lichen planus in a long-time routine blood donor never exposed to hydroxyethyl starch.
    Newman RS; Barr RJ; Ocariz JA; Kaplan HS
    Transfusion; 1983; 23(6):531-2. PubMed ID: 6196884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on low-dose hydroxyethyl starch leukapheresis. Rate of elimination of HES in vivo and function of the harvested granulocytes in vitro.
    Szymanski IO; Teno RA; Gandhi JG; Newburger PE
    Vox Sang; 1984; 47(5):325-9. PubMed ID: 6209854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A severe coagulopathy following volume replacement with hydroxyethyl starch in a Jehovah's Witness.
    Lockwood DN; Bullen C; Machin SJ
    Anaesthesia; 1988 May; 43(5):391-3. PubMed ID: 2456703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donors.
    Strauss RG; Hester JP; Vogler WR; Higby DJ; Snikeris AC; Imig KM; Greazel C; Mallard G; Burnett D; Gupta S
    Transfusion; 1986; 26(3):258-64. PubMed ID: 2422795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro comparison of the erythrocyte sedimenting properties of dextran, hydroxyethyl starch and a new low-molecular-weight hydroxyethyl starch.
    Strauss RG
    Vox Sang; 1979; 37(5):268-71. PubMed ID: 93347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relief of respiratory distress with leukapheresis in a child with chronic myelocytic leukemia.
    Moxey-Mims MM; Luban NL; Bock GH; Ruley EJ; Preston KM
    J Clin Apher; 1988; 4(1):47-9. PubMed ID: 2455709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternate dosage regimens for high molecular weight hydroxyethyl starch.
    Rock G; McCombie N
    J Clin Apher; 1985; 2(4):375-7. PubMed ID: 2415507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological effects produced by the acute and chronic administration of hydroxyethyl starch.
    Mishler JM
    J Clin Apher; 1984; 2(1):52-62. PubMed ID: 6085628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch.
    Sanfelippo MJ; Suberviola PD; Geimer NF
    Am J Clin Pathol; 1987 Nov; 88(5):653-5. PubMed ID: 2445195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyethyl starch serum levels in leukapheresis donors measured by modified periodic acid-Schiff staining technique.
    Trivedi SM; Humphrey RL; Braine HG; Frondoza CG
    Transfusion; 1984; 24(3):260-3. PubMed ID: 6203192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pruritus after administration of hetastarch.
    Br Med J (Clin Res Ed); 1982 May; 284(6326):1405-6. PubMed ID: 6176288
    [No Abstract]   [Full Text] [Related]  

  • 15. Pruritus after administration of hetastarch.
    Parker NE; Porter JB; Williams HJ; Leftley N
    Br Med J (Clin Res Ed); 1982 Feb; 284(6313):385-6. PubMed ID: 6174172
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of hydroxyethyl starch in leukocytapheresis procedures does not increase renal toxicity.
    Pagano MB; Harmon C; Cooling L; Connelly-Smith L; Mann SA; Pham HP; Marques MB; Schlueter AJ; Case R; King KE; Cataife G; Wu Y; Wong EC; Winters JL
    Transfusion; 2016 Nov; 56(11):2848-2856. PubMed ID: 27600855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method to collect granulocytes using a low dose of hydroxyethyl starch.
    Szymanski IO
    Vox Sang; 1983; 44(2):106-14. PubMed ID: 6187130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hydroxyethyl starch on erythrocyte typing and blood crossmatching.
    Daniels MJ; Strauss RG; Smith-Floss AM
    Transfusion; 1982; 22(3):226-8. PubMed ID: 6178192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternate dosage regimens for high-molecular-weight hydroxyethyl starch.
    Rock G; McCombie N
    Transfusion; 1985; 25(5):417-9. PubMed ID: 2413591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaphylactoid reactions due to hydroxyethyl starch infusion.
    Ring J; Seifert J; Messmer K; Brendel W
    Eur Surg Res; 1976; 8(5):389-99. PubMed ID: 62664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.